City

San Francisco (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of California, San Francisco (1)

Collaborator

Intervention

capmatinib (1)

ceritinib (1)

entrectinib (1)

laboratory biomarker analysis (1)

regorafenib (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

stage iii cutaneous melanoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated

ALK Fusion Protein Expression
+14 more

Capmatinib
+4 more

San Francisco, California

University of California, San Francisco

Jan 14, 2020